Drawing for VITAFISH OIL

USPTO serial 88276241

VITAFISH OIL

Reviewed by CopyMark Law Group

Reg. 6187634Status 702Renewal
Filing date
Status date
Registration date
Nov 3, 2020
Examiner
GARCIA, CLAUDIA
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with VITAFISH OIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Carlos P. Garritano

Carlos P. Garritano Tucker Ellis, LLP950 Main Ave.Suite 1100Cleveland, OH 44113

Goods and services

ClassDescriptionStatusFirst use
005Nutritional and dietary supplements as a source of anti-oxidants for the maintenance of good health, namely, vitamins, and mineral supplements; medicinal herbs; herbal supplements, nutritional supplements, and dietary supplements, used for the treatment of weight loss, aging, free radical damage, digestive complaints, irritable bowel syndrome (IBS), Crohn's, colitis, constipation, diarrhea, hormonal imbalance, menopause, polycystic ovaries, infertility, endometriosis, kidney disease, edema, high blood pressure, joint problems in the form of osteoarthritis and rheumatoid arthritis, gout, fibromyalgia, cardiovascular problems in the form of heart disease, atherosclerosis, high cholesterol, liver disease, headaches, fatty liver, skin diseases in the form of eczema, psoriasis, acne, lung disease, cough, emphysema, heavy metal toxicity, eye diseases in the form of cataracts, macular degeneration, glaucoma, sleep disorders, allergies, asthma, anxiety, veins and circulation problems, cellulite, blood sugar balance, detoxification, osteoporosis, prostate problems, fatigue; nutritional and dietary food supplements, namely, supplements containing vitamins, minerals, whole food extracts of fruits, vegetables, dietary fibre, herbal extracts, essential fatty acids, proteins as a food supplement; protein dietary supplements formed and packaged as bars, all of the foregoing goods contain fish oil in significant partACTIVEJan 31, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 10, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 10, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 10, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 22, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Nov 3, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 3, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 18, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 18, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 29, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 16, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 16, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jul 16, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 16, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 16, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 12, 2020DOCKASSIGNED TO EXAMINER—
May 2, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 2, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 2, 2020ALIEASSIGNED TO LIE—
Apr 28, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 31, 2019DOCKASSIGNED TO EXAMINER—
Apr 2, 2019DOCKASSIGNED TO EXAMINER—
Apr 2, 2019DOCKASSIGNED TO EXAMINER—
Feb 18, 2019DOCKASSIGNED TO EXAMINER—
Feb 16, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance